Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway

E-ISSN： 1873-4286|19|5|883-894

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.5, 2013-02, pp. : 883-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agents Targeting Ras Signaling Pathway

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2259-2267

Bentham Science Publishers

Access to resources Recommend Favorite

Advance in Antitumor Agents Targeting Glutathione-S-Transferase

Current Medicinal Chemistry, Vol. 13, Iss. 12, 2006-05 ,pp. : 1461-1471

Bentham Science Publishers

Access to resources Recommend Favorite

Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants

By Zhang Guang-Yi Zhang Quan-Guang

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1373-1383

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 1, 2012-01 ,pp. : 245-254

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumor Therapeutic Strategies Based on the Targeting of Epidermal Growth Factor-Induced Survival Pathways

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 289-300

Bentham Science Publishers

Access to resources Recommend Favorite